as on September 16, 2025 at 1:29 am IST
Day's Low
Day's High
0.28%
Downside
1.13%
Upside
52 Week's Low
52 Week's High
99.75%
Downside
-99.74%
Upside
Check Idexx Laboratories, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$51.3B
EPS (TTM)
12.6025
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.49%
PE Ratio (TTM)
53.47
Industry PE ratio
16.65525641025641
P/B Ratio
53.4729
PEG Ratio
4.2575
EBITDA
1.4B
Revenue (TTM)
4.0B
Profit Margin
24.41%
Return On Equity TTM
64.87%
Track how Idexx Laboratories, Inc. P/E has moved over time to understand its valuation trends.
Idexx Laboratories, Inc. in the last 5 years
Lowest (38.09x)
March 31, 2025
Industry (16.66x)
September 15, 2025
Today (53.47x)
September 15, 2025
Highest (79.24x)
September 30, 2021
Today’s Price to Earnings Ratio: 53.47x
Compare market cap, revenue, PE, and other key metrics of Idexx Laboratories, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $51.3B | 73.64% | 53.47 | 24.41% | |
BUY | $34.9B | 22.79% | 28.79 | 17.97% | |
BUY | $31.8B | 13.67% | 27.09 | 7.88% | |
BUY | $181.0B | 10.2% | 27.7 | 15.24% | |
BUY | $136.1B | -8.93% | 40.35 | 14.21% |
The Idexx Laboratories, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Idexx Laboratories, Inc. investment value today
Current value as on today
₹1,33,658
Returns
₹33,658
(+33.66%)
Returns from Idexx Laboratories, Inc. Stock
₹28,672 (+28.67%)
Dollar Returns*
₹4,985 (+4.99%)
Based on 19 analysts
68.42%
Buy
31.58%
Hold
0.00%
Sell
Based on 19 analysts, 68.42% of analysts recommend a 'BUY' rating for Idexx Laboratories, Inc.. Average target price of $695.09
Get share price movements and forecasts by analysts on Idexx Laboratories, Inc..
What analysts predicted
7.34%UPSIDE
Target Price
$695.09
Current Price
$644.07
Analyzed by
19 Analysts
Target
$695.09
Idexx Laboratories, Inc. target price $695.09, a slight upside of 7.34% compared to current price of $644.07. According to 19 analysts rating.
Search interest for Idexx Laboratories, Inc. Stock has decreased by -72% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Idexx Laboratories, Inc. has shown positive revenue growth, with an increase for the last three quarters. The revenue has risen from $954.28 million to $1.10 billion, resulting in an average quarterly growth of 7.2%.
Profit Spike
Idexx Laboratories, Inc. has shown a positive trend in its net profit over the last three quarters. The net profit increased from $216.14 million to $293.98 million, averaging a rise of 14.2% each quarter.
Price Rise
In the last 6 months, IDXX stock has moved up by 55.1%
Best in 3 Years
In the last 3 years, IDXX has outperformed top 5 stocks with highest market-cap in its industry
Best in 1 Year
In the last 1 year, IDXX has outperformed top 5 stocks with highest market-cap in its industry
Organisation | Idexx Laboratories, Inc. |
Headquarters | One IDEXX Drive, Westbrook, ME, United States, 04092 |
Industry | Health Technology |
CEO | Mr. Jonathan J. Mazelsky |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Jonathan J. Mazelsky | President, CEO & Director |
Mr. Andrew Emerson | Executive VP, CFO & Treasurer |
Ms. Sharon E. Underberg J.D. | Executive VP, General Counsel, & Corporate Secretary |
Ms. Julie Godon | Senior VP & Global Marketing Officer |
Mr. George J. Fennell | Executive Vice President of Global CAG Commercial |
Mr. Michael J. Lane | Executive VP and GM Global Reference Laboratories, Diagnostic Solutions & Information Technology |
Dr. Nimrata Khatra Hunt P.E., Ph.D. | Executive Vice President of Global Strategy & Commercial |
Dr. Martin Smith Ph.D. | Executive Vice President of Global Operations and R&D |
Mr. Bob Asmann | Senior Vice President of Global Operations |
Mr. Michael P. Johnson | Executive VP & Chief Human Resources Officer |
Idexx Laboratories, Inc. share price today is $644.07 as on at the close of the market. Idexx Laboratories, Inc. share today touched a day high of $651.33 and a low of $642.24.
Idexx Laboratories, Inc. share touched a 52 week high of $1.7 on and a 52 week low of $1.6 on . Idexx Laboratories, Inc. stock price today i.e. is closed at $644.07,which is -37786.47% down from its 52 week high and 40154.38% up from its 52 week low.
Idexx Laboratories, Inc. market capitalisation is $0.05T as on .
Indian investors can start investing in Idexx Laboratories, Inc. (IDXX) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Idexx Laboratories, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Idexx Laboratories, Inc. share’s latest price of $644.07 as on September 16, 2025 at 1:29 am IST, you will get 0.0155 shares of Idexx Laboratories, Inc.. Learn more about
fractional shares .
Idexx Laboratories, Inc. stock has given 73.64% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?